
Congress trades
Walgreens Boots Alliance, Inc. (WBA)
NASDAQ · Healthcare · 125 congress trades · last filed 12 months agono longer trading under this ticker
About Walgreens Boots Alliance, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Chief executive
- Timothy C. Wentworth
- Employees
- 193,000
- Listed since
- -
- Market value
- $10.4B
- Price to earnings
- -
- Earnings per share
- -$10.01
- Dividend yield
- 4.17%
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Oct 21, 2025 | $0.39 | $0.27 | n/a | n/a | EPS beatRevenue n/a |
| Q3 FY2025reported Jun 26, 2025 | $0.38 | $0.33 | $39.0B | $36.8B | EPS beatRevenue beat |
| Q2 FY2025reported Apr 8, 2025 | $0.63 | $0.54 | $38.6B | $38.0B | EPS beatRevenue beat |
| Q1 FY2025reported Jan 10, 2025 | $0.51 | $0.37 | $39.5B | $37.4B | EPS beatRevenue beat |
| Q4 FY2024reported Oct 15, 2024 | $0.39 | $0.36 | $37.5B | $35.8B | EPS beatRevenue beat |
| Q3 FY2024reported Jun 27, 2024 | $0.63 | $0.68 | $36.4B | $35.9B | EPS missRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2024 · proxy filed Dec 13, 2024| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Timothy WentworthChief Executive Officer | $1.3M | $11.6M | $392K | $13.3M |
| Stefano PessinaExecutive Chairman | $0 | $7.7M | $135K | $7.9M |
| Ornella BarraChief Operating Officer, International | $1.0M | $5.3M | $472K | $6.8M |
| Mary LangowskiExecutive Vice President and President, U.S. Healthcar | $432K | $4.2M | $2.1M | $6.7M |
| Manmohan MahajanGlobal Chief Financial Officer | $697K | $2.9M | $1.9M | $5.5M |
The summary compensation table from the 2024 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Congress trades in WBA
20 disclosures of 125 on record · median 29d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Val T. HoyleSpouse | Stock | Sale | $1,001 - $15,000 | 0.0%S&P 0.0% · vs S&P 500 0.0% | Aug 27, 2025 | Sep 12, 2025 | 16d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +26.5%S&P +7.1% · vs S&P 500 +19.4% | Feb 12, 2025 | Mar 12, 2025 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +8.5%S&P +8.7% · vs S&P 500 -0.2% | Feb 26, 2025 | Mar 6, 2025 | 8d |
| Julie JohnsonJoint | Stock | Purchase | $1,001 - $15,000 | -4.4%S&P +9.1% · vs S&P 500 -13.4% | Jan 15, 2025 | Feb 12, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +4.4%S&P +21.3% · vs S&P 500 -17.0% | Aug 2, 2024 | Sep 6, 2024 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +3.5%S&P +18.6% · vs S&P 500 -15.1% | Jul 1, 2024 | Aug 7, 2024 | 37d |
| Tommy TubervilleJoint | Stock | Sale (Full) | $50,001 - $100,000 | -32.4%S&P +28.8% · vs S&P 500 -61.2% | Apr 30, 2024 | May 15, 2024 | 15d |
| Tommy TubervilleJoint | Stock | Purchase | $15,001 - $50,000 | -42.4%S&P +23.5% · vs S&P 500 -65.9% | Mar 21, 2024 | Apr 15, 2024 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -41.9%S&P +24.4% · vs S&P 500 -66.3% | Mar 25, 2024 | Apr 5, 2024 | 11d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -43.2%S&P +23.9% · vs S&P 500 -67.1% | Mar 20, 2024 | Apr 5, 2024 | 16d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -42.4%S&P +41.6% · vs S&P 500 -84.0% | Dec 4, 2023 | Jan 4, 2024 | 31d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -45.8%S&P +48.8% · vs S&P 500 -94.6% | Nov 3, 2023 | Dec 6, 2023 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -46.5%S&P +48.9% · vs S&P 500 -95.4% | Oct 10, 2023 | Nov 8, 2023 | 29d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -46.6%S&P +51.4% · vs S&P 500 -97.9% | Oct 2, 2023 | Nov 8, 2023 | 37d |
| Ro Khanna | Stock | Sale | Over $50,000,000 | -47.1%S&P +45.0% · vs S&P 500 -92.0% | Sep 6, 2023 | Oct 6, 2023 | 30d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -60.5%S&P +44.1% · vs S&P 500 -104.6% | Aug 3, 2023 | Sep 6, 2023 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -59.1%S&P +45.1% · vs S&P 500 -104.2% | Aug 9, 2023 | Sep 6, 2023 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -59.5%S&P +41.7% · vs S&P 500 -101.2% | Aug 1, 2023 | Sep 6, 2023 | 36d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -53.1%S&P +44.1% · vs S&P 500 -97.1% | Aug 29, 2023 | Sep 6, 2023 | 8d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -59.4%S&P +44.2% · vs S&P 500 -103.6% | Aug 8, 2023 | Sep 6, 2023 | 29d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded WBA?
Val T. Hoyle, Julie Johnson, Gilbert Ray Cisneros, Jr., Ro Khanna, Tommy Tuberville disclosed WBA transactions in the filings shown here.
How quickly are WBA trades disclosed?
Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
